Abbvie Inc
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.
Generated $14.7 in free cash flow for every $1 of capital expenditure in FY25.
Current Price
$208.84
-2.86%GoodMoat Value
$131.68
36.9% overvaluedAbbvie Inc (ABBV) Stock Chart
ABBV Interactive Stock Chart
Interactive stock chart for Abbvie Inc (ABBV) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $208.84. 52-week high: $240.68. 52-week low: $166.12. 50-day moving average: $221.60. 200-day moving average: $214.15.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for ABBV. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Abbvie Inc's investment potential.